Elanco Animal Health Incorporated Stock price

Equities

ELAN

US28414H1032

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
16.28 USD +0.68% Intraday chart for Elanco Animal Health Incorporated -0.12% +9.26%
Sales 2024 * 4.49B Sales 2025 * 4.65B Capitalization 7.97B
Net income 2024 * -28M Net income 2025 * 82M EV / Sales 2024 * 2.86 x
Net Debt 2024 * 4.87B Net Debt 2025 * 4.38B EV / Sales 2025 * 2.65 x
P/E ratio 2024 *
-263 x
P/E ratio 2025 *
65.1 x
Employees 9,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.35%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Elanco Animal Health Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 04:05 PM
Elanco Animal Health Insider Bought Shares Worth $322,808, According to a Recent SEC Filing MT
Transcript : Elanco Animal Health Incorporated Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
Elanco Animal Health Incorporated Appoints Shiv O'Neill as Executive Vice President, General Counsel and Corporate Secretary CI
Elanco Animal Health Incorporated Sends Communication to its Employees CI
Elanco Animal Health Incorporated Issues a Statement in Response to the Submission of Nominees by Ancora Holdings Group CI
Ancora seeks four board seats at Elanco amid push for changes RE
Elanco Animal Health Issues Response to Ancora Holdings' Board Nominations MT
Transcript : Elanco Animal Health Incorporated Presents at Bank of America 2024 Animal Health Virtual Summit, Feb-29-2024 02:10 PM
Elanco Animal Health Shareholder Ancora Pushes for Board Refresh, Chief Executive Succession Plan MT
Ancora Nominates Candidates to Elanco Animal Health Board CI
Ancora seeks four board seats at Elanco amid push for changes, sources say RE
Morgan Stanley Adjusts Elanco Animal Health's Price Target to $17 From $16, Keeps Overweight Rating MT
Goldman Sachs Raises Price Target on Elanco Animal Health to $14 From $12.50, Maintains Sell Rating MT
Barclays Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Overweight Rating MT
More news
1 day+0.68%
1 week+0.62%
Current month+2.45%
1 month-1.09%
3 months+10.00%
6 months+46.40%
Current year+9.26%
More quotes
1 week
15.78
Extreme 15.78
16.43
1 month
15.52
Extreme 15.515
16.73
Current year
13.91
Extreme 13.91
16.88
1 year
7.88
Extreme 7.88
16.88
3 years
7.88
Extreme 7.88
37.49
5 years
7.88
Extreme 7.88
37.49
10 years
7.88
Extreme 7.88
37.61
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 18-06-30
Director of Finance/CFO 52 18-12-13
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 61 20-12-13
Director/Board Member 62 19-05-07
Director/Board Member 68 19-03-10
More insiders
Date Price Change Volume
24-03-28 16.28 +0.68% 2,321,926
24-03-27 16.17 +1.76% 2,022,403
24-03-26 15.89 -0.13% 2,792,961
24-03-25 15.91 +0.57% 1,899,513
24-03-22 15.82 -2.94% 2,516,541

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
16.28 USD
Average target price
17.09 USD
Spread / Average Target
+4.98%
Consensus
  1. Stock
  2. Equities
  3. Stock Elanco Animal Health Incorporated - Nyse